ETF PRO AIAugust 23, 2026
XPH SPDR S&P Pharmaceuticals ETF
Fund tearsheet · data as of the latest session · August 23, 2026
ONE YEAR OF DAILY CLOSES
0.35%expense ratio
$561Mfund assets
+31.9%return, YTD
+53.8%return, 1 year
+$53Mnet flow, 1 month
+$247Mnet flow, 1 year
22.7%realized volatility, 1y
-12.1%worst drawdown, 1y
Top ten holdings
| 1 | AMLX AMYLYX PHARMACEUTICALS | 2.04% |
| 2 | CRNX CRINETICS PHARMACEUTICALS | 1.66% |
| 3 | MBX MBX Biosciences | 2.72% |
| 4 | ATAI ATAI LIFE SCIENCES NV | 2.13% |
| 5 | DFTX Definium Therapeutics | 3.09% |
| 6 | OMER OMEROS | 1.42% |
| 7 | ELVN ENLIVEN THERAPEUTICS | 2.09% |
| 8 | CORT CORCEPT THERAPEUTICS | 1.70% |
| 9 | NUVB NUVATION BIO | 1.89% |
| 10 | ETON ETON PHARMACEUTICALS | 1.30% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS